Basal bolus insulin regimens are commonly used in individuals with T1D to emulate the physiological action of defunct pancreatic beta cells; basal insulin provides long-acting stable glucose control, whereas bolus insulin provides rapid-acting prandial glucose control (Vliebergh et al., 2021). This evidence concerns the gene INS and type 1 diabetes mellitus.